. 2019 May 13;9:7289. doi: 10.1038/s41598-019-43838-8

Table 6.

Effect of Iranian Propolis on lipid profile in T2DM patients after 90 days.

Variables	Propolis(n = 50)		Placebo(n = 44)		P-Value^a
Variables	Before	After	Before	After	P-Value^a
Triglycerides, mg/dl	162.8 ± 73.16	174.41 ± 101.91	164.52 ± 121.46	176.74 ± 83.59	0.91
Total cholesterol, mg/dl	149 ± 39.62	156.39 ± 42.98	153 ± 43.91	150.08 ± 38.96	0.488
HDL cholesterol, mg/dl	44.66 ± 8.69	48.91 ± 9.32^b	43.98 ± 10.21	44.21 ± 9.24	0.024
LDL cholesterol, mg/dl	71.73 ± 29.48	70.59 ± 32.11	75.84 ± 26.2	73.67 ± 28.1	0.646
VLDL cholesterol, mg/dl	31.91 ± 13.81	37.28 ± 20.31	33.36 ± 27.27	32.71 ± 16.62	0.269

^aComparison of change between placebo and Iranian propolis values after 90 days. ^bP < 0.05 for baseline versus after 90 days within the group. Data are mean ± standard deviation. HDL, high-density lipoprotein; LDL, low-density lipoprotein; VLDL, very low-density lipoprotein.